Neuroone Medical Technologies (NMTC) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.04, -1.89% vs the prior close of $1.06.
- Volume 169.00K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NMTC dips 1.9% to $1.04. Closed at $1.04, -1.89% vs the prior close of $1.06. Day range $1.01β$1.09, opened at $1.05.
NMTC daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β NMTC dips 1.9% to $1.04
- Closed at $1.04, -1.89% vs the prior close of $1.06. Day range $1.01β$1.09, opened at $1.05.
- Volume was 169.00K shares, 0.4x its 50-day average of 417.81K β lighter than usual.
- Price is -31.3% vs its 50-day average ($1.51) and -69.7% vs its 200-day average ($3.44).
- 52-week range $0.96β$6.12; today's close sits at 2% of that range, 83.0% below the 52-week high.
Oct 14, 2026 β NMTC slides 3.6% to $1.06
- Closed at $1.06, -3.64% vs the prior close of $1.10. Day range $1.06β$1.09, opened at $1.09.
- Volume was 57.50K shares, 0.1x its 50-day average of 419.89K β lighter than usual.
- Price is -30.6% vs its 50-day average ($1.53) and -69.3% vs its 200-day average ($3.45).
- 52-week range $0.96β$6.12; today's close sits at 2% of that range, 82.7% below the 52-week high.
Oct 13, 2026 β NMTC rises 2.3% to $1.10
- Closed at $1.10, +2.33% vs the prior close of $1.08. Day range $1.05β$1.14, opened at $1.08.
- Volume was 108.30K shares, 0.3x its 50-day average of 418.20K β lighter than usual.
- Price is -28.5% vs its 50-day average ($1.54) and -68.3% vs its 200-day average ($3.47).
- 52-week range $0.96β$6.12; today's close sits at 3% of that range, 82.0% below the 52-week high.
Oct 12, 2026 β NMTC slides 4.0% to $1.08
- Closed at $1.08, -4.02% vs the prior close of $1.12. Day range $1.05β$1.11, opened at $1.10.
- Volume was 39.70K shares, 0.1x its 50-day average of 417.62K β lighter than usual.
- Price is -30.7% vs its 50-day average ($1.55) and -69.2% vs its 200-day average ($3.49).
- 52-week range $0.96β$6.42; today's close sits at 2% of that range, 83.3% below the 52-week high.
Oct 9, 2026 β NMTC jumps 3.7% to $1.12
- Closed at $1.12, +3.70% vs the prior close of $1.08. Day range $1.04β$1.14, opened at $1.07.
- Volume was 80.10K shares, 0.2x its 50-day average of 416.23K β lighter than usual.
- Price is -28.4% vs its 50-day average ($1.56) and -68.0% vs its 200-day average ($3.50).
- 52-week range $0.96β$6.54; today's close sits at 3% of that range, 82.9% below the 52-week high.
Oct 8, 2026 β NMTC dips 2.7% to $1.08
- Closed at $1.08, -2.70% vs the prior close of $1.11. Day range $1.07β$1.12, opened at $1.09.
- Volume was 315.30K shares, 0.8x its 50-day average of 410.58K.
- Price is -31.4% vs its 50-day average ($1.57) and -69.3% vs its 200-day average ($3.52).
- 52-week range $0.96β$6.72; today's close sits at 2% of that range, 83.9% below the 52-week high.
Oct 7, 2026 β NMTC dips 1.8% to $1.11
- Closed at $1.11, -1.77% vs the prior close of $1.13. Day range $1.09β$1.15, opened at $1.13.
- Volume was 115.80K shares, 0.3x its 50-day average of 409.13K β lighter than usual.
- Price is -30.0% vs its 50-day average ($1.59) and -68.6% vs its 200-day average ($3.54).
- 52-week range $0.96β$6.96; today's close sits at 2% of that range, 84.1% below the 52-week high.
Oct 6, 2026 β NMTC rises 1.3% to $1.13
- Closed at $1.13, +1.35% vs the prior close of $1.12. Day range $1.10β$1.17, opened at $1.13.
- Volume was 110.00K shares, 0.3x its 50-day average of 407.65K β lighter than usual.
- Price is -29.3% vs its 50-day average ($1.60) and -68.2% vs its 200-day average ($3.55).
- 52-week range $0.96β$6.96; today's close sits at 3% of that range, 83.8% below the 52-week high.
Oct 5, 2026 β NMTC dips 0.4% to $1.12 on 2.6x normal volume
- Closed at $1.12, -0.45% vs the prior close of $1.12. Day range $1.10β$1.35, opened at $1.18.
- Volume was 1.00M shares, 2.6x its 50-day average of 388.45K β unusually heavy trading.
- Price is -30.7% vs its 50-day average ($1.61) and -68.8% vs its 200-day average ($3.57).
- 52-week range $0.96β$6.96; today's close sits at 3% of that range, 84.0% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 2, 2026 β NMTC jumps 13.7% to $1.12
- Closed at $1.12, +13.71% vs the prior close of $0.99. Day range $0.98β$1.20, opened at $0.98.
- Volume was 197.40K shares, 0.5x its 50-day average of 385.00K β lighter than usual.
- Price is -31.1% vs its 50-day average ($1.63) and -68.8% vs its 200-day average ($3.58).
- 52-week range $0.96β$6.96; today's close sits at 3% of that range, 83.9% below the 52-week high.
NMTC latest news & SEC filings
Every SEC filing by or about NMTC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 8.01 β Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 8, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Wambeke David J. bought 33,333 shares at $2.01 (β$67.00K) on Aug 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 13, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.97M (prior year $1.70M) (+16.3% vs Jun 30, 2025)
- Net income: -$2.01M (prior year -$1.50M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.28 (prior year -$0.19) (loss widened vs Jun 30, 2025)
Aug 13, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade NMTC
- Last results release: Oct 5, 2026 (8-K Item 2.02). Previous ones: Aug 13, 2026, May 12, 2026, Feb 17, 2026. Based on that rhythm, the next report is likely around Jan 4, 2027 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.12% (largest 16.2%). That is a volatile stock.
- Liquidity: about 176.97K shares (β$184.05K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.04 vs a range of $0.96β$6.12 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:6 on Apr 16, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 6 sales; latest: David J. Wambeke bought 33,333 shares on Aug 27, 2026.
- Latest filings: 8-K Oct 5, 2026; 8-K Aug 27, 2026; 10-Q Aug 13, 2026.
- Share count: 9.11M shares outstanding (Aug 11, 2026), -81.8% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
NMTC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.05 | 1.09 | 1.01 | 1.04 | 169.00K |
| Oct 14, 2026 | 1.09 | 1.09 | 1.06 | 1.06 | 57.50K |
| Oct 13, 2026 | 1.08 | 1.14 | 1.05 | 1.10 | 108.30K |
| Oct 12, 2026 | 1.10 | 1.11 | 1.05 | 1.08 | 39.70K |
| Oct 9, 2026 | 1.07 | 1.14 | 1.04 | 1.12 | 80.10K |
| Oct 8, 2026 | 1.09 | 1.12 | 1.07 | 1.08 | 315.30K |
| Oct 7, 2026 | 1.13 | 1.15 | 1.09 | 1.11 | 115.80K |
| Oct 6, 2026 | 1.13 | 1.17 | 1.10 | 1.13 | 110.00K |
| Oct 5, 2026 | 1.18 | 1.35 | 1.10 | 1.12 | 1.00M |
| Oct 2, 2026 | 0.98 | 1.20 | 0.98 | 1.12 | 197.40K |
| Oct 1, 2026 | 1.03 | 1.07 | 0.96 | 0.99 | 125.40K |
| Sep 30, 2026 | 1.13 | 1.14 | 1.01 | 1.03 | 68.00K |
| Sep 29, 2026 | 1.29 | 1.32 | 1.05 | 1.09 | 315.40K |
| Sep 28, 2026 | 1.31 | 1.34 | 1.29 | 1.30 | 30.20K |
| Sep 25, 2026 | 1.33 | 1.35 | 1.28 | 1.33 | 120.80K |
| Sep 24, 2026 | 1.36 | 1.39 | 1.33 | 1.33 | 191.00K |
| Sep 23, 2026 | 1.40 | 1.42 | 1.34 | 1.34 | 167.70K |
| Sep 22, 2026 | 1.34 | 1.40 | 1.31 | 1.38 | 100.60K |
| Sep 21, 2026 | 1.41 | 1.41 | 1.30 | 1.30 | 77.70K |
| Sep 18, 2026 | 1.39 | 1.40 | 1.35 | 1.39 | 149.50K |
About Neuroone Medical Technologies
Neuroone Medical Technologies (NMTC) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in EDEN PRAIRIE, MN. State of incorporation: DE. Fiscal year ends September 30. SEC CIK 1500198.
NMTC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Edward Andrle | Director | Apr 7, 2026 |
| Paul Buckman | Director | Apr 7, 2026 |
| Jeffrey S Mathiesen | Director | Apr 7, 2026 |
| Jason Richard Mills | Director | Apr 7, 2026 |
| David A Rosa | CEO & President | Aug 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark Christianson | Market Development Director | Aug 28, 2026 |
| Emily J. Johns | Chief Administrative Officer | Aug 28, 2026 |
| Steve Mertens | Chief Technology Officer | Aug 28, 2026 |
| David A Rosa | CEO & President | Aug 28, 2026 |
| Christopher Volker | Chief Financial Officer | Aug 28, 2026 |
| David J. Wambeke | Chief Business Officer | Sep 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | David J. Wambeke | Buy | 33,333 | $2.01 |
| Jun 30, 2026 | Mark Christianson | Sale | 10,000 | $3.18 |
| Mar 30, 2026 | Mark Christianson | Sale | 15,363 | $0.74 |
| Mar 13, 2026 | Mark Christianson | Sale | 100 | $0.80 |
| Mar 12, 2026 | Mark Christianson | Sale | 817 | $0.80 |
| Mar 11, 2026 | Mark Christianson | Sale | 2,109 | $0.80 |
| Mar 10, 2026 | Mark Christianson | Sale | 11,611 | $0.80 |
| Mar 1, 2026 | David J. Wambeke | Buy | 1,000,000 | $0.67 |
NMTC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | $9.10M | $-3.61M | -0.09 | $-2.84M |
| Sep 30, 2024 | $3.45M | $-12.32M | -0.46 | $-11.01M |
| Sep 30, 2023 | $1.95M | $-11.86M | -0.65 | $-12.89M |
| Sep 30, 2022 | $171.17K | $-10.00M | -0.63 | $-7.52M |
| Sep 30, 2021 | $178.15K | $-9.95M | -0.93 | $-8.60M |
Latest balance sheet: total assets $6.19M, total liabilities $2.42M, cash $2.05M (as of Jun 30, 2026).
NMTC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 5, 2026 | 8-K Item 2.02 (results) | $1.12 |
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.83 |
| May 12, 2026 | 8-K Item 2.02 (results) | $4.39 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $4.07 |
| Dec 17, 2025 | 8-K Item 2.02 (results) | $4.01 |
| Oct 6, 2025 | 8-K Item 2.02 (results) | $5.98 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $4.98 |
| May 13, 2025 | 8-K Item 2.02 (results) | $3.86 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $6.72 |
| Jan 10, 2025 | 8-K Item 2.02 (results) | $6.79 |
| Dec 17, 2024 | 8-K Item 2.02 (results) | $4.75 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NMTC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.